Navigation Links
Cancer Drug Doesn't Speed Up Tumor Growth, Researchers Say
Date:2/7/2013

THURSDAY, Feb. 7 (HealthDay News) -- The anticancer drug Sutent (sunitinib) does not cause tumors to grow faster after treatment ends, according to a new study.

Previous research in animals suggested that tumor growth may accelerate after patients stopped taking Sutent. The new findings, from a study of kidney cancer patients, indicate that the drug does not pose lingering risks for humans.

The researchers analyzed data from a phase 3 clinical trial that led to Sutent's approval. They concluded that regardless of how long patients took the drug, it did not cause harm, did not speed up tumor growth and survival was not shortened after treatment ended, according to the findings published online Feb. 7 in the journal Cell Reports.

During treatment, Sutent slowed tumor growth and extended patients' lives, the investigators pointed out in a journal news release.

Sutent, which is approved for the treatment of several different cancers, targets proteins on the blood vessels that feed tumors.

"Last year, I was approached by two patients who had grave concerns about taking sunitinib due to an article [about research] conducted in animals. I realized that if clinical data exist that refute basic science, they must be published," study senior author Dr. Tito Fojo, of the U.S. National Cancer Institute, said in the news release.

These new findings should reassure patients, the study authors suggested.

"We hope [these findings] can be generalized to similar drugs but recognize that further studies will be needed," study first author Dr. Krastan Blagoev, of the U.S. National Science Foundation, said in the news release. "Nevertheless, other drugs also approved worldwide for a variety of cancers -- including sorafenib, pazopanib, and axitinib -- are similar to sunitinib, and this will give some reassurances that one need not expect things to get worse after such drugs are discontinued."

More information

The U.S. National Library of Medicine has more about sunitinib (Sutent).

-- Robert Preidt

SOURCE: Cell Reports, news release, Feb. 7, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug Doesn't Speed Up Tumor Growth, Researchers Say
(Date:3/1/2017)... ... March 01, 2017 , ... ... announce the release of its 2017 update to Compass, the popular online ... physician advisors. , Suitable for standardizing both new-hire on-boarding and annual competency-validation, ...
(Date:3/1/2017)... ... , ... Expert on international living and leading a healthy lifestyle, Alina Reyzelman, ... & Go app is the ultimate strategic compass that helps users to achieve goals ... people to work smarter, not harder, that's why Time & Go app provides tools ...
(Date:3/1/2017)... ... ... is Comfort for the Soul”: a loving account of a very special dog, the ... soul-healing comfort provided by God’s presence in the face of deep sorrow. “There is ... dog-loving medical professional whose work takes her to remote areas in the American Northwest, ...
(Date:3/1/2017)... ... ... to the Law of God”: a message about the revelation of God to our dark ... God” is the creation of published author Brent Chrishon, a former sales professional who left ... dedicated their lives to spreading God’s word both in the United States and abroad. , ...
(Date:2/28/2017)... ... February 28, 2017 , ... Answering strong demand for its medical ... will open a branch office in the Soma neighborhood in San Francisco on March ... factors, FDA regulatory and software systems architecture subject matter experts. , Orthogonal serves a ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Acute Myeloid Leukemia Drugs Price ... in the global Acute Myeloid Leukemia market. This research ... find out how the marketed products for Acute Myeloid Leukemia are ...
(Date:3/1/2017)... El mismo sistema se mostrará en el Congreso Europeo de Radiología (CER) ... ... The open MRI scanner - MROpen engineered and developed by Paramed in the ... Paramed ... primera en Gales. El escáner se localizará en el nuevo centro del European Scanning Centre ...
(Date:2/28/2017)... 2017 Persistence Market Research tables a ... market in a new publication named, "Dysphagia Management ... the name suggests, we have forecasted the global ... on the basis of the various market segments ... opportunities available to all the companies operating in ...
Breaking Medicine Technology: